Hochschulschrift
Simulation of oral absorption with physiologically based pharmacokinetic models with a focus on weakly basic active pharmaceutical ingredients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
Seite A-F, 180 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Literaturverzeichnis Seiten 61-68
Goethe-Universität in Frankfurt am Main, Dissertation, 2018
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wann)
-
[2018]
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- [2018]
Ähnliche Objekte (12)
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin